(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Ubunyulu ≥98.0% (HPLC) Rivaroxaban Intermediate Factory

Inkcazelo emfutshane:

Igama leMichiza: (S)-(+)-Glycidyl Phthalimide

CAS: 161596-47-0

Imbonakalo: Mhlophe ukuya kwi-Off-White Powder

Ubunyulu: ≥98.0% (HPLC)

Umbindi weRivaroxaban (CAS: 366789-02-8) kunyango lwe-Venous Thromboembolism (VTE)

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo loMvelisi iRivaroxaban eNxulumeneyo nabaPhakathi:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-enye CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
I-5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Iipropati zeMichiza:

Igama leMchiza	(S)-(+)-Glycidyl Phthalimide
Izithethantonye	(S)-Glycidyl Phthalimide;(S)-N-Glycidylphthalimide;Rivaroxaban Intermediate
Inombolo yeCAS	161596-47-0
Inombolo yeCAT	RF-PI128
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C11H9NO3
Ubunzima beMolekyuli	203.19
Indawo yokunyibilika	102℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mhlophe ukuya kwi-Off-White Powder
Ukuchongwa	HPLC
Ilahleko ekomisweni	≤0.50%
I-Sulfate Ash	≤0.50%
Ubunyulu / Indlela yokuHlalutya	≥98.0% (HPLC)
I-Phthalimide	≤0.10%
Ukungacoceki koMax omnye	≤0.50%
Ukungcola ngokupheleleyo	≤2.0%
Epichlorohydrin	≤0.10%
Glycidol	≤0.10%
Ucoceko lweChiral	I-R-isomer ≤2.0% (HPLC)
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Rivaroxaban (CAS: 366789-02-8) Phakathi

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Synthesis Route

Ukupakishwa kunye noGcino:

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) kunye nomgangatho ophezulu.Kuphakathi ngokuqhelekileyo kwi-synthesis yeRivaroxaban (CAS: 366789-02-8), kunyango lwe-Venous Thromboembolism (VTE).

I-Rivaroxaban (Xarelto; CAS: 366789-02-8) ichiza le-antithrombotic kwaye yaphuhliswa ngokubambisana phakathi kwe-German Bayer Pharmaceuticals kunye nenkampani yaseMelika Johnson.I-Rivaroxaban iboniswa kunyango lwe-thrombosis ye-vein deep kunye ne-pulmonary embolism, kunye nokuthintela i-thrombosis ye-deep vein thrombosis kunye ne-pulmonary embolism kubantu abadala.